CCP
AGN

Corient Capital Partners’s Allergan plc AGN Stock Holding History

Corient Capital Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-3,962
Closed -$702K – 524
2020
Q1 		$702K Buy
3,962
+417
+12% +$78.5K 0.11% 159
2019
Q4 		$678K Buy
3,545
+403
+13% +$72.7K 0.09% 236
2019
Q3 		$529K Buy
3,142
+960
+44% +$156K 0.07% 248
2019
Q2 		$365K Buy
2,182
+134
+7% +$18.6K 0.06% 278
2019
Q1 		$300K Buy
+2,048
New +$297K 0.05% 280
2018
Q4 		– Sell
-1,415
Closed -$269K – 324
2018
Q3 		$269K Hold
1,415
– – 0.04% 236
2018
Q2 		$236K Buy
+1,415
New +$227K 0.04% 242
2017
Q4 		– Sell
-1,105
Closed -$227K – 291
2017
Q3 		$227K Sell
1,105
-5,307
-83% -$1.23M 0.04% 254
2017
Q2 		$1.56M Buy
6,412
+282
+5% +$66.3K 0.24% 107
2017
Q1 		$1.47M Buy
6,130
+1,383
+29% +$322K 0.23% 107
2016
Q4 		$997K Buy
4,747
+2,403
+103% +$498K 0.18% 128
2016
Q3 		$540K Buy
+2,344
New +$573K 0.1% 184

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Corient Capital Partners's AGN Position: Q2 2020 in Review

Corient Capital Partners sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 3,962 shares — an estimated $702K sold.

Corient Capital Partners first reported a position in AGN in Q3 2016 and held it in 12 quarters. The position peaked at $1.56M in Q2 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Corient Capital Partners reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Corient Capital Partners sold 3,962 Allergan plc shares in Q2 2020, an estimated $702K.
  • Corient Capital Partners first reported a position in Allergan plc in Q3 2016 and held it in 12 quarters.
  • Corient Capital Partners's Allergan plc position peaked at $1.56M in Q2 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Corient Capital Partners's 13F filing for Q2 2020, filed 14 Aug 2020.